Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 10 years, Hunan Nucien Pharmaceutical Co's highest Yield on Cost was 1.99. The lowest was 0.81. And the median was 1.12.
SHSE:688189's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.36 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Hunan Nucien Pharmaceutical Co (SHSE:688189) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hunan Nucien Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms
SHSE:688189 vs ZTS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Nucien Pharmaceutical Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.
Hunan Nucien Pharmaceutical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. Over the past decade, Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % has ranged from 0.81 to 1.99. According to the industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 507 companies in the Drug Manufacturers industry.
Is Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % too high?
Hunan Nucien Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.99. Based on the distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 507 companies for 5-Year Yield-on-Cost %. This places Hunan Nucien Pharmaceutical Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. Historically, Hunan Nucien Pharmaceutical Co's own 5-Year Yield-on-Cost % has ranged from 0.81 to 1.99 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.36, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hunan Nucien Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.31, compared to a current price of ¥6.40 — trading 177.1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥6.40 is trading 177.1% above its estimated GF Value™ of ¥2.31.
GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:688189:
5-Year Yield-on-Cost %: 0.00
GF Value™: ¥2.31 vs. price of ¥6.40 (177.1% above fair value)
No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
52GF Score
Get the complete analysis for SHSE:688189
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688189 has been successfully added to your 
